2.5 Ethical considerations Ethical approval was not required for this review, as it did not involve the collection of primary data
Due to their specific actions and relatively minor systemic effects, peptide-based therapies are quickly gaining popularity in the wellness, fitness, and rehabilitation industries
The 50s protocol is about restoring function in systems that have already changed
Richard Frank, MD, MHSA, Chief Medical Officer at Vida Health, spoke to Medical News Today about how orforglipron may expand access to GLP-1s: The choice between a pill and an injectable comes down to patient preference and potency. The injectables are clearly more potent but require a weekly injection
Immune research has identified IGF1R expression on T cells, B cells, and macrophages